Back to search

University of Patras

Αξιολόγηση του ρόλου λιποπρωτεϊνών του ορού και των απολιποπρωτεϊνών τους με έμφαση στην απολιποπρωτεΐνη Α2, στην εμφάνιση συστατικών στοιχείων του μεταβολικού συνδρόμου

Abstract

dc:description

Apolipoprotein A2 (APOA2) has been characterized as the second most abundant apolipoprotein in HDL, although it has also been detected in other lipoprotein fractions, especially under dyslipidemic conditions. Although it has been studied for several decades, its exact role in lipid metabolism, in the regulation of the lipoprotein profile, and in the development of disorders associated with metabolic syndrome remains unclear. The available evidence is conflicting, as some studies suggest a protective role against atherosclerosis, whereas others associate it with proatherogenic effects. Based on these observations, the aim of the present doctoral thesis was to investigate the role of APOA2, as well as that of serum lipoproteins and their apolipoproteins, in the development of the individual components of metabolic syndrome, and to assess whether natural and pharmacological interventions can modify the underlying processes. The present study was organized into three research parts, each using different mouse models according to the specific objective. In the first part, the effect of human APOA2 on lipid and lipoprotein metabolism, as well as on the metabolic activity of adipose tissue, was examined through adenoviral gene transfer in C57BL/6, ldlr-/-, and apoe-/- mice. The results showed that the action of APOA2 depends to a large extent on the genetic and metabolic background. In C57BL/6 mice, its expression increased cholesterol and triglyceride levels, whereas in ldlr-/- mice it was associated with reduced total cholesterol and triglycerides, as well as reductions in all major lipoprotein fractions. In apoe-/- mice, no substantial changes were observed in total lipid levels, but a clear redistribution of lipids among the individual lipoprotein fractions was detected. In parallel, APOA2 also affected the distribution of other apolipoproteins, while in the dyslipidemic models it was associated with suppression of the thermogenic activity of adipose tissue. The second part examined the effect of a Lavandula stoechas leaf extract, encapsulated in maltodextrin, in C57BL/6 mice at three different doses. Its effects on APOA2 expression and distribution, as well as on lipid, glycemic, and metabolic parameters, were assessed. The findings showed a dose-dependent modification of APOA2 distribution. The lower doses were associated with reduced APOA2 in HDL, increased triglycerides, impaired glucose tolerance, and suppressed thermogenesis. In contrast, the highest dose induced redistribution of APOA2 into non-HDL fractions and was accompanied by improvement in the lipid profile, reduced fasting glucose, preservation of glucose tolerance, improved anti-inflammatory and antioxidant HDL function, and enhanced thermogenic activity in brown adipose tissue. The third part investigated the effect of the omega-3 agent icosapent ethyl (IPE) in ldlr-/- mice, a model of complete LDL receptor deficiency. IPE administration reduced total plasma cholesterol and triglycerides, decreased hepatic VLDL triglyceride secretion, remodeled HDL fractions with reduced APOA2 and APOB in HDL, and increased the metabolic activation of white adipose tissue. These findings show that IPE affects not only hepatic and lipoprotein metabolism, but also peripheral metabolic activity. Overall, this thesis supports that APOA2 is a regulator of the lipoprotein and metabolic phenotype whose action depends on the biological background. Its distribution between HDL and non-HDL fractions appears to be functionally important and can be modified by both natural and pharmacological interventions, with effects on lipid metabolism, glucose metabolism, and adipose tissue function. These findings support further investigation of APOA2 as a potential biomarker and therapeutic target in metabolic syndrome.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kakafoni, Georgia
  • Κακαφώνη, Γεωργία

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62131

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kakafoni, Georgia; Κακαφώνη, Γεωργία. Αξιολόγηση του ρόλου λιποπρωτεϊνών του ορού και των απολιποπρωτεϊνών τους με έμφαση στην απολιποπρωτεΐνη Α2, στην εμφάνιση συστατικών στοιχείων του μεταβολικού συνδρόμου. University of Patras, 2026. http://hdl.handle.net/10442/hedi/62131